Akebia Therapeutics: Q2 Earnings Insights

Akebia Therapeutics AKBA reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Akebia Therapeutics beat estimated earnings by 148.39%, reporting an EPS of $0.15 versus an estimate of $-0.31.

Revenue was up $73.85 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 23.89% increase in the share price the next day.

To track all earnings releases for Akebia Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.